Saudi Pharm J. 2013 Apr;21(2):165-8. doi: 10.1016/j.jsps.2012.05.008. Epub 2012 May 26.
Hospital versus home treatment of deep vein thrombosis in a tertiary care hospital in Saudi Arabia: Are we ready?.
Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Farjah Algahtani, Zohair Al Aseri, Abdurahman Aldiab, Aamer Aleem
Affiliations
Affiliations
- Hematology-Oncology Division, Department of Medicine, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia.
PMID: 23960831
PMCID: PMC3745076 DOI: 10.1016/j.jsps.2012.05.008
Abstract
AIM/BACKGROUND: Treatment of DVT with LMWHs has been shown recently to be as effective as UFH with suggested lower costs. This study was conducted to determine and compare the cost of in-patient hospital treatment versus outpatient hospital treatment of patients with DVT.
METHOD: All adult patients with acute proximal DVT referred to the Emergency Department of King Khalid University Hospital, Riyadh, Saudi Arabia between August 2009 and August 2010 were invited to the study. An economic analysis was performed to compare the cost impact of outpatients versus hospital treatment.
RESULTS: Sixty-one patients were included in the study, 31 were followed in the outpatient setting and 30 as the control group (inpatients). There were no significant differences in the outcome between the outpatient and inpatient group; three patients (9.7%) in the outpatient group and four patients (13.3%) in the inpatient group had recurrent DVT. Mean nursing cost was $55 for the outpatient group and $215 for the inpatient group, mean laboratory monitoring cost was $638 for outpatient group and $1511 for the inpatient group. Hospital stay and doctor's fees amounted to a mean of $1000 for outpatient treatment and $2387 for inpatient treatment, p < 0.0001. The mean outpatient cost was significantly lower than the inpatient cost ($1750 vs. $4338, p < 0.0001).
CONCLUSION: Outpatient treatment of patients with DVT using LMWHs is cost-effective with no significant differences in the outcome of patients. OPD treatment of DVT is feasible in Saudi Arabia provided there is enough logistic support from thrombosis clinics and those involved in DVT care.
Keywords: Anticoagulation; Deep vein thrombosis; Economic evaluation; Outpatient; Patient safety; Treatment
References
- Thromb Haemost. 1998 Feb;79(2):259-63 - PubMed
- Arch Intern Med. 1993 Jul 12;153(13):1541-6 - PubMed
- Arch Intern Med. 1998 Mar 23;158(6):585-93 - PubMed
- Ann Intern Med. 1999 May 18;130(10):789-99 - PubMed
- BMJ. 1994 Jul 30;309(6950):299-304 - PubMed
- Am J Cardiol. 2004 Jan 15;93(2):259-62 - PubMed
- Ann Intern Med. 2001 Feb 6;134(3):191-202 - PubMed
- Thromb Res Suppl. 1991;14:49-62 - PubMed
- Arch Intern Med. 1999 May 24;159(10):1139-40 - PubMed
- N Engl J Med. 1991 May 30;324(22):1565-74 - PubMed
- J Intern Med. 1992 Aug;232(2):155-60 - PubMed
- Circulation. 1976 Apr;53(4):691-5 - PubMed
- Thromb Haemost. 1996 Aug;76(2):195-9 - PubMed
- Lancet. 1992 Feb 22;339(8791):441-5 - PubMed
- Angiology. 1999 Oct;50(10):781-7 - PubMed
- Thromb Haemost. 1994 Aug;72(2):186-90 - PubMed
- J Intern Med. 1996 Dec;240(6):395-401 - PubMed
- Arch Intern Med. 1995 Mar 27;155(6):601-7 - PubMed
- Arch Intern Med. 2000 Oct 23;160(19):2926-32 - PubMed
- Arch Intern Med. 1997 Dec 8-22;157(22):2562-8 - PubMed
- N Engl J Med. 1997 Sep 4;337(10):657-62 - PubMed
- N Engl J Med. 1992 Apr 9;326(15):975-82 - PubMed
- Am J Med. 1996 Mar;100(3):269-77 - PubMed
Publication Types